Activation of glycogen synthase kinase-3 inhibits long term potentiation with synapse-associated imp

来源 :中国神经科学学会第四次会员代表大会暨第七届全国学术会议(The 7th Biennial Meeting and the | 被引量 : 0次 | 上传用户:chamlea
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Activation of glycogen synthase kinase-3 (GSK-3) can cause memory deficits as seen in Alzheimer disease (AD),the most common age-associated dementia,but the mechanism is not understood.Here,we found that activation of GSK-3 by wortmannin or transient overexpression of wild type GSK-3β (wtGSK-3β) could suppress the induction of long term potentiation (LTP) in rat hippocampus,while simultaneous inhibition of GSK-3 by lithium or SB216763 or transient expression of a dominant negative GSK-3β mutant (dnGSK-3β) preserved the LTP.After high frequency stimulation (HFS),the presynaptic release of glutamate and the expression/clustering of synapsin Ⅰ,a synaptic vesicle protein playing an important role in neurotmnsmitter release,decreased markedly upon upregulation of GSK-3.
其他文献
会议
会议
会议
会议
预测植物病人(VS)的意识恢复是临床上的一个难题.最近的研究表明,被试自己名字(SON)可能是解决这一问题的有效的工具.目的 观察SON诱发波形对VS病人意识恢复的预测作用,同时与N100,MMN和P300对VS病人意识恢复的预测能力进行比较.被试和方法 13名严重脑损伤病人参加本研究,包括4名comatose病人,7名VS和2名微意识病人(MCS).CRS-R量表作为VS和MCS病人的诊断依据.
Infantile neuroaxonal dystrophy (INAD) is a rare autosomal recessive neurodegerative disorder involving both central nervous system and peripheral axons.The clinical picture is characterized by psycho
目的 探讨电针对大鼠海洛因成瘾的干预作用以及电针治疗海洛因成瘾的神经通路和生物学机制.方法 SD成年雄性大鼠随机分为四组:空白对照组、海洛因戒断组(或复吸组)、电针加捆帮处理组和捆帮组(或留针加捆帮组).大鼠按逐日递增原则每日分3次皮下注射海洛因,从第1天的7.5 mg/kg起,直到第9天的67.5 mg/kg,建立大鼠海洛因躯体依赖模型.电针处理组大鼠在每天注射海洛因后电针治疗一次,每次30 m
Clinical and experimental evidences have indicated that females appear to be more vulnerable than males to the reinforcing effects of psychostimulants.Gender differences have been repeated demonstrate
The aberrant proteolytic processing of amyloid precursor protein (APP) by b-secretase (BACE 1) and g-secretase is important for the generation of beta-amyloid protein in the Alzheimers disease (AD) br